ArticleBMC cancer2022

Impact of fibrinogen levels and modified Glasgow prognostic score on survival of stage III/N2 non-small cell lung cancer patients treated with neoadjuvant therapy and radical resection.

Katharina Sinn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.